AS Watson, the owner of UK health and beauty retailer Superdrug, is allegedly eyeing a US$30bn dual Initial Public Offering (IPO) listing in 2026.
The international health and beauty conglomerate, which also owns fragrance retailer The Perfume Shop, would allegedly raise an estimated $2bn by floating on stock exchange firms in London, UK, and Hong Kong, China, according to a new report.
It is rumoured that the primary location of the float is still being decided on by AS Watsons’ owner, CK Hutchison, a Hong Kong-based multinational conglomerate, according to people familiar with the matter who spoke with The Financial Times.
Have you launched an innovative product, brand or campaign in the past 12 months? Then you could be in with a chance of winning at this year's new and improved Pure Beauty Awards 2026. Click here for more information.
An AS Watson spokesperson told Cosmetics Business: “For clarity, we do not comment on market speculation, and no decision has been made at CK Hutchison regarding any potential IPO of AS Watson Group.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.